|
1
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akhtar-Danesh N, Lytwyn A and Elit L:
Five-year trends in mortality indices among gynecological cancer
patients in Canada. Gynecol Oncol. 127:620–624. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crow JM: HPV: The global burden. Nature.
488:S2–S3. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Devi Prabha K and Priya Bindhu N:
Conventional Pap smear screening in HIV seropositive women in South
India. J Obstet Gynaecol India. 63:55–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hofmeyer KA, Ray A and Zang X: The
contrasting role of B7-H3. Proc Natl Acad Sci USA. 105:10277–10278.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leung J and Suh WK: The CD28-B7 family in
anti-tumor immunity: Emerging concepts in cancer immunotherapy.
Immune Netw. 14:265–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, et al: B7-H3: A
costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang G, Hou J, Shi J, Yu G, Lu B and
Zhang X: Soluble CD276 (B7-H3) is released from monocytes,
dendritic cells and activated T cells and is detectable in normal
human serum. Immunology. 123:538–546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun M, Richards S, Prasad DVR, Mai XM,
Rudensky A and Dong C: Characterization of mouse and human B7-H3
genes. J Immunol. 168:6294–6297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ling V, Wu PW, Spaulding V, Kieleczawa J,
Luxenberg D, Carreno BM and Collins M: Duplication of primate and
rodent B7-H3 immunoglobulin V- and C-like domains: Divergent
history of functional redundancy and exon loss. Genomics.
82:365–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: A novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu H, Cheung IY, Guo HF and Cheung NKV:
MicroRNA miR-29 modulates expression of immunoinhibitory molecule
B7-H3: Potential implications for immune based therapy of human
solid tumors. Cancer Res. 69:6275–6281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamato I, Sho M, Nomi T, Akahori T,
Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H and Nakajima Y:
Clinical importance of B7-H3 expression in human pancreatic cancer.
Br J Cancer. 101:1709–1716. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arigami T, Narita N, Mizuno R, Nguyen L,
Ye X, Chung A, Giuliano AE and Hoon DSB: B7-h3 ligand expression by
primary breast cancer and associated with regional nodal
metastasis. Ann Surg. 252:1044–1051. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brunner A, Hinterholzer S, Riss P, Heinze
G and Brustmann H: Immunoexpression of B7-H3 in endometrial cancer:
Relation to tumor T-cell infiltration and prognosis. Gynecol Oncol.
124:105–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi
Y, Shi JY, Xu YF, Shi YH, Song K, et al: B7-H3 is expressed in
human hepatocellular carcinoma and is associated with tumor
aggressiveness and postoperative recurrence. Cancer Immunol
Immunother. 61:2171–2182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ingebrigtsen VA, Boye K, Tekle C, Nesland
JM, Flatmark K and Fodstad O: B7-H3 expression in colorectal
cancer: Nuclear localization strongly predicts poor outcome in
colon cancer. Int J Cancer. 131:2528–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Zhang Q, Chen W, Shan B, Ding Y,
Zhang G, Cao N, Liu L and Zhang Y: B7-H3 is overexpressed in
patients suffering osteosarcoma and associated with tumor
aggressiveness and metastasis. PLoS One. 8:e706892013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong
F, Zhang ZX, Zhang GB, Zhang XG and Zhao H: B7-H3 overexpression in
pancreatic cancer promotes tumor progression. Int J Mol Med.
31:283–291. 2013.PubMed/NCBI
|
|
20
|
Chen C, Shen Y, Qu QX, Chen XQ, Zhang XG
and Huang JA: Induced expression of B7-H3 on the lung cancer cells
and macrophages suppresses T-cell mediating anti-tumor immune
response. Exp Cell Res. 319:96–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W,
Zhang W, Li J, Zhang S and Qiu H: Expression of costimulatory
molecule B7-H3 and its prognostic implications in human acute
leukemia. Hematology. 20:187–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JT, Chen CH, Ku KL, Hsiao M, Chiang
CP, Hsu TL, Chen MH and Wong CH: Glycoprotein B7-H3 overexpression
and aberrant glycosylation in oral cancer and immune response. Proc
Natl Acad Sci USA. 112:13057–13062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guery T, Roumier C, Berthon C, Renneville
A, Preudhomme C and Quesnel B: B7-H3 protein expression in acute
myeloid leukemia. Cancer Med. 4:1879–1883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwai Y, Ishida M, Tanaka Y, Okazaki T,
Honjo T and Minato N: Involvement of PD-L1 on tumor cells in the
escape from host immune system and tumor immunotherapy by PD-L1
blockade. Proc Natl Acad Sci USA. 99:12293–12297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Topalian SL, Drake CG and Pardoll DM:
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor
immunity. Curr Opin Immunol. 24:207–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suh WK, Gajewska BU, Okada H, Gronski MA,
Bertram EM, Dawicki W, Duncan GS, Bukczynski J, Plyte S, Elia A, et
al: The B7 family member B7-H3 preferentially down-regulates T
helper type 1-mediated immune responses. Nat Immunol. 4:899–906.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zang X, Thompson RH, Al-Ahmadie HA, Serio
AM, Reuter VE, Eastham JA, Scardino PT, Sharma P and Allison JP:
B7-H3 and B7x are highly expressed in human prostate cancer and
associated with disease spread and poor outcome. Proc Natl Acad Sci
USA. 104:19458–19463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lemke D, Pfenning PN, Sahm F, Klein AC,
Kempf T, Warnken U, Schnölzer M, Tudoran R, Weller M, Platten M, et
al: Costimulatory protein 4IgB7H3 drives the malignant phenotype of
glioblastoma by mediating immune escape and invasiveness. Clin
Cancer Res. 18:105–117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tekle C, Nygren MK, Chen YW, Dybsjord I,
Nesland JM, Maelandsmo GM and Fodstad O: B7-H3 contributes to the
metastatic capacity of melanoma cells by modulation of known
metastasis-associated genes. Int J Cancer. 130:2282–2290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tindle RW: Immune evasion in human
papillomavirus-associated cervical cancer. Nat Rev Cancer. 2:59–65.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Greenwald RJ, Freeman GJ and Sharpe AH:
The B7 family revisited. Annu Rev Immunol. 23:515–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L: Co-inhibitory molecules of the
B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol.
4:336–347. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen X, Wang L, Wang W, Zhao L and Shan B:
B7-H4 facilitates proliferation of esophageal squamous cell
carcinoma cells through promoting interleukin-6/signal transducer
and activator of transcription 3 pathway activation. Cancer Sci.
107:944–954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng L, Jiang J, Gao R, Wei S, Nan F, Li
S and Kong B: B7-H4 expression promotes tumorigenesis in ovarian
cancer. Int J Gynecol Cancer. 19:1481–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abadi YM, Jeon H, Ohaegbulam KC,
Scandiuzzi L, Ghosh K, Hofmeyer KA, Lee JS, Ray A, Gravekamp C and
Zang X: Host b7x promotes pulmonary metastasis of breast cancer. J
Immunol. 190:3806–3814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Salceda S, Tang T, Kmet M, Munteanu A,
Ghosh M, Macina R, Liu W, Pilkington G and Papkoff J: The
immunomodulatory protein B7-H4 is overexpressed in breast and
ovarian cancers and promotes epithelial cell transformation. Exp
Cell Res. 306:128–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun X, Vale M, Leung E, Kanwar JR, Gupta R
and Krissansen GW: Mouse B7-H3 induces antitumor immunity. Gene
Ther. 10:1728–1734. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu
KF, Zhao JM, Zhang GB and Zhang XG: Relationship between
co-stimulatory molecule B7-H3 expression and gastric carcinoma
histology and prognosis. World J Gastroenterol. 12:457–459. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Benzon B, Zhao SG, Haffner MC, Takhar M,
Erho N, Yousefi K, Hurley P, Bishop JL, Tosoian J, et al:
Correlation of B7-H3 with androgen receptor, immune pathways and
poor outcome in prostate cancer: An expression-based analysis.
Prostate Cancer Prostatic Dis. 20:28–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xie C, Liu D, Chen Q, Yang C, Wang B and
Wu H: Soluble B7-H3 promotes the invasion and metastasis of
pancreatic carcinoma cells through the TLR4/NF-κB pathway. Sci Rep.
6:275282016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang W, Wang J, Wang Y, Dong F, Zhu M,
Wan W, Li H, Wu F, Yan X and Ke X: B7-H3 silencing by RNAi inhibits
tumor progression and enhances chemosensitivity in U937 cells. Onco
Targets Ther. 8:1721–1733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mao Y, Li W, Chen K, Xie Y, Liu Q, Yao M,
Duan W, Zhou X, Liang R and Tao M: B7-H1 and B7-H3 are independent
predictors of poor prognosis in patients with non-small cell lung
cancer. Oncotarget. 6:3452–3461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yuan H, Wei X, Zhang G, Li C, Zhang X and
Hou J: B7-H3 over expression in prostate cancer promotes tumor cell
progression. J Urol. 186:1093–1099. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang W, Wang Y, Wang J, Dong F, Zhu M,
Wan W, Li H, Wu F, Yan X and Ke X: B7-H3 silencing inhibits tumor
progression of mantle cell lymphoma and enhances chemosensitivity.
Int J Oncol. 46:2562–2572. 2015.PubMed/NCBI
|
